glucagon-like peptide-1

FDA okays unique injectable for type 2 diabeticsFDA approvedĀ a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.
GLP-1 targeted therapy may help diabetes patientsThe role of ophthalmologists will become increasingly more vital in the management of type 2 diabetes as the numbers of patients with the disease is projected to double by 2030. Exenatide may prove to be an important adjunct to current oral anti-diabetes drugs.